BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 18558304)

  • 61. Use of cinacalcet in a patient on long-term dialysis with end-stage renal failure and refractory secondary hyperparathyroidism.
    Dorsch O
    Nephrol Dial Transplant; 2007 Feb; 22(2):637-40. PubMed ID: 17095580
    [No Abstract]   [Full Text] [Related]  

  • 62. Cinacalcet-induced hungry bone syndrome.
    Lazar ES; Stankus N
    Semin Dial; 2007; 20(1):83-5. PubMed ID: 17244128
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Clinical utilization of cinacalcet in hypercalcemic conditions.
    Messa P; Alfieri C; Brezzi B
    Expert Opin Drug Metab Toxicol; 2011 Apr; 7(4):517-28. PubMed ID: 21361849
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cinacalcet: benefit and cost.
    Cohen E
    Nephrol Dial Transplant; 2008 Apr; 23(4):1460; author reply 1460. PubMed ID: 18065795
    [No Abstract]   [Full Text] [Related]  

  • 65. Emerging roles of cinacalcet hydrochloride in the management of CKD-MBD.
    Fukagawa M; Suzuki M
    Ther Apher Dial; 2009 Oct; 13 Suppl 1():S1. PubMed ID: 19765251
    [No Abstract]   [Full Text] [Related]  

  • 66. Regression of tumoral calcinosis after the appropriate control of a deranged mineral and bone metabolism, in conjugation with cinacalcet hydrochloride treatment, in a chronic hemodialysis patient.
    Yamada S; Tsuruya K; Kitazono T
    Ther Apher Dial; 2013 Jun; 17(3):348-9. PubMed ID: 23735152
    [No Abstract]   [Full Text] [Related]  

  • 67. Treatment of secondary hyperparathyroidism of dialysis patients with calcimimetics as a valuable addition to established therapeutic means.
    Drüeke TB
    Pediatr Nephrol; 2005 Mar; 20(3):399-403. PubMed ID: 15662538
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cinacalcet for secondary hyperparathyroidism in hemodialysis recipients.
    Ureña Torres PA; Chanard J
    N Engl J Med; 2004 Jul; 351(2):188-9; author reply 188-9. PubMed ID: 15250062
    [No Abstract]   [Full Text] [Related]  

  • 69. Normalization of serum calcium by cinacalcet in a patient with hypercalcaemia due to a de novo inactivating mutation of the calcium-sensing receptor.
    Timmers HJ; Karperien M; Hamdy NA; de Boer H; Hermus AR
    J Intern Med; 2006 Aug; 260(2):177-82. PubMed ID: 16882283
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Early and severe hyperparathyroidism associated with hypercalcemia after renal transplant treated with cinacalcet.
    Leca N; Laftavi M; Gundroo A; Kohli R; Min I; Karam J; Sridhar N; Blessios G; Venuto R; Pankewycz O
    Am J Transplant; 2006 Oct; 6(10):2391-5. PubMed ID: 16869807
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cinacalcet as first-line treatment for calciphylaxis.
    Pallure V; Comte C; Leray-Mouragues H; Dereure O
    Acta Derm Venereol; 2008; 88(1):62-3. PubMed ID: 18176755
    [No Abstract]   [Full Text] [Related]  

  • 72. Parathyroidectomy in the calcimimetic era.
    Elder GJ
    Nephrology (Carlton); 2005 Oct; 10(5):511-5. PubMed ID: 16221104
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cost-utility analysis of cinacalcet in addition to standard of care in the UK.
    Ray JA; Valentine WJ; Palmer AJ
    Nephrol Dial Transplant; 2007 Nov; 22(11):3355-7; author reply 3357-8. PubMed ID: 17785347
    [No Abstract]   [Full Text] [Related]  

  • 74. Cinacalcet should be used to treat secondary hyperparathyroidism in stage 3-4 chronic kidney disease.
    de Francisco AL; Piñera C; Palomar R
    Nat Clin Pract Nephrol; 2008 Jul; 4(7):366-7. PubMed ID: 18506170
    [No Abstract]   [Full Text] [Related]  

  • 75. Asymptomatic polyostotic Paget's disease associated with secondary hyperparathyroidism in a peritoneal dialysis patient.
    De Sousa-Amorim E; Del Peso-Gilsanz G; Bajo-Rubio MA; Selgas-Gutiérrez R
    Nefrologia; 2012 Jul; 32(4):542-4. PubMed ID: 22806296
    [No Abstract]   [Full Text] [Related]  

  • 76. Calcimimetics and calcilytics--fooling the calcium receptor.
    Steddon SJ; Cunningham J
    Lancet; 2005 Jun 25-Jul 1; 365(9478):2237-9. PubMed ID: 15978932
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Six cases of successful cinacalcet cessation in haemodialysis patients treated for secondary hyperparathyroidism.
    Jean G; Chazot C; Charra B
    Nephrol Dial Transplant; 2007 Jul; 22(7):2102-3. PubMed ID: 17395648
    [No Abstract]   [Full Text] [Related]  

  • 78. Secondary hyperparathyroidism in chronic renal failure. Effects of renal homotransplantation.
    Johnson JW; Hattner RS; Hampers CL; Bernstein DS; Merrill JP; Sherwood LM
    JAMA; 1971 Jan; 215(3):478-80. PubMed ID: 4923754
    [No Abstract]   [Full Text] [Related]  

  • 79. Mineral metabolism: Should cinacalcet be used in patients who are not on dialysis?
    Cannata-Andía JB; Fernández-Martín JL
    Nat Rev Nephrol; 2009 Jun; 5(6):307-8. PubMed ID: 19474823
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Lithium hypercalcemia, hyperparathyroidism, and cinacalcet.
    Gregoor PS; de Jong GM
    Kidney Int; 2007 Mar; 71(5):470. PubMed ID: 17315015
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.